Leading Cell Culture Companies Shaping Market Growth and Innovation to 2031
The global Cell culture market is projected to grow from USD 33.07 billion in 2026 to USD 58.42 billion by 2031, at a CAGR of 12.1% during the forecast period. The market was valued at USD 30.23 billion in 2025. The growth of the cell culture market is driven by the rising demand for biologics and biosimilars, expanding vaccine production, increasing adoption of cell and gene therapy and regenerative...
mRNA Synthesis and Manufacturing Market by Region: Key Trends, Growth Drivers, and Forecast to 2029
The global mRNA synthesis and manufacturing market is expanding as advancements in mRNA-based vaccines, therapeutics, and biopharmaceutical development reshape the life sciences industry. The market is projected to reach USD 2.96 billion by 2029, up from an estimated USD 2.23 billion in 2024, registering a CAGR of 5.8% during the forecast period.
The increasing demand for mRNA vaccines in clinical...
Genetic Engineering Market to Reach USD 5.93 Billion by 2029
The global Genetic Engineering Market is projected to grow from USD 3.73 billion in 2024 to USD 5.93 billion by 2029, registering a CAGR of 9.7% during the forecast period. Market growth is driven by the increasing demand for personalized medicine, rising adoption of gene therapy, expanding applications of CRISPR and gene delivery technology, and growing investments in cell-based therapies,...
Exosome Therapy Market: Growth, Trends, Opportunities, and Future Outlook
The exosome therapy market is emerging as a promising area of biotechnology and regenerative medicine, driven by growing research into extracellular vesicles and their ability to transport biological molecules between cells. Exosomes are being investigated for their potential applications in targeted drug delivery, cancer treatment, regenerative medicine, neurological disorders, cardiovascular...
Extracellular Vesicles Market: Growth, Trends, Opportunities, and Future Outlook
The extracellular vesicles market is gaining significant attention as researchers, biotechnology companies, pharmaceutical organizations, and diagnostic developers explore the potential of extracellular vesicles (EVs) in disease diagnosis, drug delivery, biomarker discovery, and therapeutic development.
Extracellular vesicles are membrane-bound particles released by cells that facilitate...
Exosomes Market: Growth, Trends, Opportunities, and Future Outlook
The exosomes market is emerging as a significant area of growth within biotechnology, life sciences, diagnostics, and therapeutic research. Exosomes are small extracellular vesicles released by cells that carry biological molecules such as proteins, lipids, and RNA. Their role in cell-to-cell communication has generated growing interest in applications ranging from disease biomarkers and...
Preimplantation Genetic Diagnosis Market to Reach USD 1,135.0 Million by 2030
The global Preimplantation Genetic Diagnosis Market is projected to grow from USD 690.2 million in 2025 to USD 1,135.0 million by 2030, registering a CAGR of 10.5% during the forecast period. Market growth is being driven by the increasing prevalence of genetic disorders and infertility, rising adoption of assisted reproductive technologies, particularly IVF, and...
Genetically Modified Mice Market to Reach USD 2.74 Billion by 2030
The global Genetically modified mice Market is projected to grow from USD 1.70 billion in 2025 to USD 2.74 billion by 2030, registering a CAGR of 10.0% during the forecast period. Market growth is being driven by the increasing use of mice models in preclinical research, rising demand for genetically engineered disease models, growing adoption of personalized medicine,...
Residual DNA Testing Market to Reach USD 0.37 Billion by 2030
The global Residual DNA Testing Market is projected to grow from USD 0.28 billion in 2025 to USD 0.37 billion by 2030, registering a CAGR of 6.0% during the forecast period. The market’s growth is primarily driven by increasing regulatory approvals for biologics and biosimilars, stringent product safety and quality requirements, and rising investments in advanced therapeutic...
Epigenetics Market: Growth, Trends, Drivers, and Emerging Opportunities Through 2031
The global epigenetics market is entering a period of strong expansion as researchers, pharmaceutical companies, biotechnology firms, and clinical laboratories increasingly adopt technologies that can reveal how gene activity is regulated without changing the underlying DNA sequence. The market is projected to grow from USD 2.22 billion in 2026 to USD 3.92 billion by 2031, registering a CAGR of 12.0%...